The Center for Global Health Policy and HIVMA released a policy statement (PDF) this month, calling for greater investment domestically and globally in HIV treatment in light of the results of the HIV Prevention Trial Networks (HPTN) 052 study. The study found that early initiation of antiretroviral therapy (ART) for HIV-infected patients reduced their chances of sexually transmitting HIV to their uninfected partners by more than 96 percent.
The Center and HIVMA recommend that a larger share of the President's Emergency Plan for AIDS Relief (PEPFAR) budget be devoted to treatment; that ART be included in studies of combination prevention strategies, and that HIV counseling and testing, including couples counseling, be expanded in all venues. The policy statement also calls for an evaluation of PEPFAR prevention expenditures based on evidence of efficacy and a redeployment of resources from less efficacious interventions to those known to be effective, including ART.
In addition, the groups call for prioritizing domestic HIV funding for early HIV diagnosis with reliable and ongoing linkage and access to HIV care and treatment; and for fully funding the Ryan White program and addressing state waiting lists for ART medication.
Check out the Science Speaks blog for more information.
< Previous Article | Next Article >